Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
Times cited: 53
Amsacrine retains a special role supporting Food and Drug Administration approval .
Journal of Clinical Oncology.
Times cited: 1
'Quality' remissions: A new target of induction therapy in acute leukemia and the next step in developing curative treatment.
Seminars in Hematology.
Times cited: 9
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.
Times cited: 20